Repurposed Drug Shows Promise in Repairing Brain DNA and Lowering Inflammation in Alzheimer’s Research

Photo: Aakash Dhage / Unsplash
Researchers have found that an experimental drug originally created for spinal cord injuries can successfully address core drivers of Alzheimer's disease, including cellular DNA damage and brain inflammation. Because the compound has already undergone initial human safety testing, it may significantly accelerate the timeline for developing targeted, root-cause treatments.
Researchers have found that an experimental drug originally created for spinal cord injuries can successfully address core drivers of Alzheimer’s disease, including cellular DNA damage and brain inflammation. Because the compound has already undergone initial human safety testing, it may significantly accelerate the timeline for developing targeted, root-cause treatments.